116 related articles for article (PubMed ID: 38460939)
1. Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains.
Phillips M; Malone KL; Boyle BW; Montgomery C; Kressy IA; Joseph FM; Bright KM; Boyson SP; Chang S; Nix JC; Young NL; Jeffers V; Frietze S; Glass KC
J Med Chem; 2024 May; 67(10):8186-8200. PubMed ID: 38733345
[TBL] [Abstract][Full Text] [Related]
2. Biological function and histone recognition of family IV bromodomain-containing proteins.
Lloyd JT; Glass KC
J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
[TBL] [Abstract][Full Text] [Related]
3. Acetyllysine-binding and function of bromodomain-containing proteins in chromatin.
Dyson MH; Rose S; Mahadevan LC
Front Biosci; 2001 Aug; 6():D853-65. PubMed ID: 11487465
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression.
Bursch KL; Goetz CJ; Jiao G; Nuñez R; Olp MD; Dhiman A; Khurana M; Zimmermann MT; Urrutia RA; Dykhuizen EC; Smith BC
J Biol Chem; 2024 Apr; 300(4):107146. PubMed ID: 38460939
[TBL] [Abstract][Full Text] [Related]
5. PBRM1 bromodomains variably influence nucleosome interactions and cellular function.
Slaughter MJ; Shanle EK; McFadden AW; Hollis ES; Suttle LE; Strahl BD; Davis IJ
J Biol Chem; 2018 Aug; 293(35):13592-13603. PubMed ID: 29986887
[TBL] [Abstract][Full Text] [Related]
6. Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma.
Porter EG; Dykhuizen EC
J Biol Chem; 2017 Feb; 292(7):2601-2610. PubMed ID: 28053089
[TBL] [Abstract][Full Text] [Related]
7. High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1.
Liao L; Alicea-Velázquez NL; Langbein L; Niu X; Cai W; Cho EA; Zhang M; Greer CB; Yan Q; Cosgrove MS; Yang H
Mol Oncol; 2019 Apr; 13(4):811-828. PubMed ID: 30585695
[TBL] [Abstract][Full Text] [Related]
8. PBRM1 bromodomains associate with RNA to facilitate chromatin association.
De Silva SM; Dhiman A; Sood S; Mercedes KF; Simmons WJ; Henen MA; Vögeli B; Dykhuizen EC; Musselman CA
Nucleic Acids Res; 2023 May; 51(8):3631-3649. PubMed ID: 36808431
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Recombinant Histones and Widom 601 DNA for Reconstitution of Nucleosome Core Particles.
Paintsil EA; Morrison EA
Methods Mol Biol; 2023; 2599():163-175. PubMed ID: 36427149
[TBL] [Abstract][Full Text] [Related]
10. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
Shishodia S; Nuñez R; Strohmier BP; Bursch KL; Goetz CJ; Olp MD; Jensen DR; Fenske TG; Ordonez-Rubiano SC; Blau ME; Roach MK; Peterson FC; Volkman BF; Dykhuizen EC; Smith BC
J Med Chem; 2022 Oct; 65(20):13714-13735. PubMed ID: 36227159
[TBL] [Abstract][Full Text] [Related]
11. Interpreting the spectrum of gamma-secretase complex missense variation in the context of hidradenitis suppurativa-An
Mintoff D; Pace NP; Borg I
Front Genet; 2022; 13():962449. PubMed ID: 36118898
[TBL] [Abstract][Full Text] [Related]
12. Update on the treatment of metastatic renal cell carcinoma.
Medina López RA; Rivero Belenchon I; Mazuecos-Quirós J; Congregado-Ruíz CB; Couñago F
World J Clin Oncol; 2022 Jan; 13(1):1-8. PubMed ID: 35116228
[TBL] [Abstract][Full Text] [Related]
13. Proteome-wide mapping of short-lived proteins in human cells.
Li J; Cai Z; Vaites LP; Shen N; Mitchell DC; Huttlin EL; Paulo JA; Harry BL; Gygi SP
Mol Cell; 2021 Nov; 81(22):4722-4735.e5. PubMed ID: 34626566
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]